| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.002 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |